Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 120   

Articles published

GSK 1,644.38 -5.12 (-0.31%)
price chart
GlaxoSmithKline PLC (NYSE:GSK) Given Price Target Of $49.5
As per GlaxoSmithKline PLC (NYSE:GSK)'s news release on 2016-07-27, its shareholders will get cash dividend of $0.494 per share.
Stocks inside Analysts Limelight: Merck & Company, Inc. (NYSE:MRK ...
GlaxoSmithKline PLC (NYSE:GSK) showed bullish move with gain of +0.14% after exchanging volume of 2.13 million shares in last trading session ended on 8/29/2016.
GlaxoSmithKline PLC (NYSE:GSK): The Buzzing Stock
The research entity Zacks released its research report on GlaxoSmithKline PLC (NYSE:GSK) as per, which its stock can move to hit $50 in the approaching fiscal.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Survive From New Respiratory Molecule ...
GlaxoSmithKline's plc (ADR) (NYSE:GSK) respiratory franchise is going through a tough time due to fierce competition after the patent expiration of the company's blockbuster drugs and with the induction of generics in the therapeutic market.
Shire PLC Lags GlaxoSmithKline plc, AstraZeneca plc, Pfizer Inc. And Johnson ...
This is less than the gains made by global sector peers such as GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN), Pfizer Inc. (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ).
GlaxoSmithKline plc 1.5% Potential Upside Indicated by Cantor Fitzgerald
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'HOLD' today by analysts at Cantor Fitzgerald.
A report released earlier today by Cantor Fitzgerald about (LON:GSK ...  Breaking Finance News
Plentiful money Inflow: Nokia Corporation (NYSE:NOK) , GlaxoSmithKline PLC ...
On 8/26/2016, Nokia Corporation (NYSE:NOK) ended trading session lower at $5.69 with -0.18%. The company traded a volume of 8.05 million shares as comparison to average volume of 12.19 million shares.
GlaxoSmithKline PLC (NYSE:GSK)'s Stock In Limelight
There is a possibility of sell-side analysts having to use alternate terminology to explain their Buy/Sell recommendations. However, this solely depends on the research firm.
3 Stocks in Focus: Mylan N.V. (MYL), Amicus Therapeutics (FOLD), The ...  iStreetWire
GlaxoSmithKline plc 11.3% Potential Upside Indicated by JP Morgan Cazenove
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'NEUTRAL' today by analysts at JP Morgan Cazenove.
JP Morgan Indicates Potential 10.98% Increase In Shares Of GlaxoSmithKline PLC  Fiscal Standard
What can Google do that GlaxoSmithKline plc cannot?
The UK medical giant GlaxoSmithKline (LSE: GSK) has announced a new partnership with the Alphabet life science's division Verily to create a UK based start-up called Galvani Bioelectronics.